News
Vetter’s Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of...
News
Indian Pharmaceutical Industry Now And In The Days To Come
It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater...
News
Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of...
News
FDA may permit Pfizer COVID vaccine for kids up to 5 years
Dr Anthony Fauci, the chief medical advisor to the White House has gone on to confirm that FDA might as well approve the Pfizer...
Packaging & Labelling
Vetter’s new clinical manufacturing site now officially authorized
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria. As a...
Clinical Trials
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir...
News
Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patients
Stempeutics, a group company of Manipal Education and Medical Group (MEMG) said it has received DCGI clearance to conduct Phase 3 clinical trial on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read